ParAccel Unveils ‘Unconstrained' Enterprise Analytics Pricing Model

john-santaferraro-paraccel
John Santaferraro, VP of solutions and product marketing, ParAccel

Campbell, Calif.-based analytic database vendor ParAccel is rolling out a new licensing model, dubbed Right to Deploy, which allows customers to use its ParAccel Analytic Platform throughout their firms without any constraints placed on the amount of data, number of users, analytics or nodes, for the price of a single license, to provide firms with a more flexible model as data volumes and data requirements continue to grow.

The vendor already offers a per-node licensing model that lets firms

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@waterstechnology.com or view our subscription options here: http://subscriptions.waterstechnology.com/subscribe

You are currently unable to copy this content. Please contact info@waterstechnology.com to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Waterstechnology? View our subscription options

‘Feature, not a bug’: Bloomberg makes the case for Figi

Bloomberg created the Figi identifier, but ceded all its rights to the Object Management Group 10 years ago. Here, Bloomberg’s Richard Robinson and Steve Meizanis write to dispel what they believe to be misconceptions about Figi and the FDTA.

Where have all the exchange platform providers gone?

The IMD Wrap: Running an exchange is a profitable business. The margins on market data sales alone can be staggering. And since every exchange needs a reliable and efficient exchange technology stack, Max asks why more vendors aren’t diving into this space.

Most read articles loading...

You need to sign in to use this feature. If you don’t have a WatersTechnology account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here